C

Researcher Profile

Caitlyn Stromko

1

Publications

186

Citations

10

Co-Authors

1

Active Years

Publications

Open Access Journal Article The Lancet May 01, 2025

Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial

Thomas Yau · Peter R Galle · Thomas Decaens · Bruno Sangro +24 more

10.1016/s0140-6736(25)00403-9 186 citations

Publication Timeline

2025

1

Frequent Co-Authors

Leonardo G da Fonseca

Maria Jesus Jimenez Exposito

Armando Santoro

Jean-Frédéric Blanc

Joanna Wójcik-Tomaszewska

Gonzalo Pizarro